Sarah Boyce is President and Chief Executive Officer of Atrium Therapeutics, Inc. (RNA). The company reported total compensation of $14,176,480 for fiscal year 2024.
| Salary | $659,900 |
|---|---|
| Bonus | $0 |
| Stock awards | $10,748,480 |
| Option awards | $2,157,090 |
| Non-equity incentive plan | $594,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $17,010 |
| Total | $14,176,480 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Atrium Therapeutics, Inc. filed April 29, 2025, accession 0001599901-25-000092.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2024 | President and Chief Executive Officer | $659,900 | $0 | $10,748,480 | $2,157,090 | $594,000 | $0 | $17,010 | $14,176,480 |
| FY2023 | President and Chief Executive Officer | $634,500 | $0 | $2,766,000 | $7,374,840 | $349,000 | $0 | $15,379 | $11,139,719 |
| FY2022 | President and Chief Executive Officer | $601,400 | $0 | $0 | $4,319,275 | $430,100 | $0 | $15,336 | $5,366,111 |
Totals as disclosed in each year's own compensation disclosure for Atrium Therapeutics, Inc..
| Peer-group chief executive median | $5,640,713 |
|---|---|
| Difference from that median | $8,535,767 |
| Percentile within the disclosed peer group | 88th |
| Peers with a disclosed figure | 16 |
Medians and percentiles are computed across the peer group Atrium Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2024 total |
|---|---|---|
| Sarah Boyce this page | President and Chief Executive Officer | $14,176,480 |
| John Moriarty | Chief Legal Officer and Corporate Secretary | $9,699,196 |
| Michael MacLean | Chief Financial Officer | $4,941,722 |
| W. Michael Flanagan | Chief Scientific Officer | $4,802,896 |
| Teresa McCarthy | Chief Human Resources Officer | $4,622,733 |
The company's named executive officers for fiscal year 2024, and what it reported for each. See the full Atrium Therapeutics, Inc. compensation brief.
Sarah Boyce's compensation sits inside Atrium Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.